Market Research Logo

Global Continuous Glucose Monitoring Market (CGM): Size, Trends & Forecasts (2016-2020)

Global Continuous Glucose Monitoring Market (CGM): Size, Trends & Forecasts (2016-2020)

Scope of the Report

The report titled “Global Continuous Glucose Monitoring Market (CGM): Size, Trends & Forecasts (2016-2020)”, provides an in-depth analysis of the global CGM market. The report also gives an insight of the global CGM market by value, by penetration, by products, by components, by region, etc.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global CGM market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The competition in global CGM market is dominated by the two big players, DexCom Incorporation and Medtronic. Further, key players of the CGM market DexCom, Incorporation, Medtronic and Abbott Laboratories are also profiled with their financial information and respective business strategies.

Country Coverage

North America
Western Europe
China

Company Coverage

Abbott Laboratories
DexCom Incorporation
Medtronic

Executive Summary

Continuous Glucose Monitoring (CGM) is a small glucose sensor (electrodes) inserted under the skin that keeps in check the glucose levels in interstitial fluid. The sensor stays in body for several days to a week before being replaced. A transmitter that is placed on the body sends information about the level of glucose via radio waves from the sensor to a wireless monitor that could be in the form of a wristband or it could be an app on the smartphone that allows the patient to view their glucose measurements. The CGM system basically has been designed to target the type1 diabetic population, for the early detection of hypo and hyperglycemia. The CGM system is made of three parts: a wireless monitor (receiver), a transmitter and a sensor. The CGM market has several advantages and disadvantages.

Global CGM market has increased at a significant CAGR during the years 2014-2015 and projections are made that the market would rise in the next four years i.e. 2016-2020 tremendously. The CGM market is expected to increase due to increasing population with type1 diabetes, sedentary lifestyle, rising population with obesity, etc. Yet, the market faces some challenges such as, intense competition in the market, lack of penetration in type 2 diabetes, lack of reliability and accuracy in data.


1. Executive Summary
2. Introduction
2.1 Diabetes: An Overview
2.1.1 Types of Diabetes
Table 1: Types of Diabetes
2.1.2 Symptoms of Diabetes
Table 2: Symptoms of Diabetes
2.1.3 Diagnosis of Diabetes
2.1.4 Treatment for Diabetes
2.1.5 Instruments/Gadgets/Apps to Manage Diabetes
Table 3: Instruments/Gadgets/Apps to Manage Diabetes
2.1.6 Composition of Diabetes Device Market
Table 4: Composition of Diabetes Device Market
2.2 Continuous Glucose Monitoring (CGM): An Overview
Table 5: CGM System
2.2.1 Advantages & Disadvantages of CGM
2.3 BGM v/s CGM
2.3.1 Blood Glucose Monitoring (BGM) v/s Continuous Glucose Monitoring (CGM)
Table 6: Blood Glucose Monitoring (BGM) v/s Continuous Glucose Monitoring (CGM)
3. Global Market Analysis
3.1 Global Diabetes Market: An Analysis
3.1.1 Global Diabetic Populatio
Table 7: Global Diabetic Population; 2009-2020 (Million)
3.1.2 Global Diabetic Population by Region
Table 8: Regional Distribution of Global Diabetic Population; 2015
3.2 Global Diabetes Device Market: An Analysis
3.2.1 Global Diabetes Device Market/Glucose Monitoring Market by Value
Table 9: Global Diabetes Device Market/Glucose Monitoring Market by Value; 2014-2021 (US$ Billion)
3.2.2 Global Diabetes Device Market by Segments
Table 10: Global Diabetes Device Market by Segments; 2015 and 2021
3.3 Global CGM Market: An Analysis
3.3.1 Global CGM Market by Value
Table 11: Global CGM Market by Value; 2014-2021 (US$ Million)
3.3.2 Global CGM Market by Segments
Table 12: Global CGM Market by Segments; 2015
3.3.3 Global CGM Market by Regions
Table 13: Global CGM Market by Regions; 2015
4. Regional Market Analysis
4.1 North America CGM Market: An Analysis
4.1.1 North America CGM Market by Value
Table 14: North America CGM Market by Value; 2015-2020 (US$ Million)
4.1.2 US Diabetic Population
Table 15: US Diabetic Population; 2013-2020 (Million)
4.1.3 US Diabetic Population by Diagnosis
Table 16: US Diabetic Population by Diagnosis; 2015
4.1.4 US Diabetes Population by Segments
Table 17: US Diabetes Population by Segments; 2013-2020 (Million)
4.1.5 US Type 1 Diabetic Population on the Basis of Management
Table 18: US Type 1 Diabetic Population on the Basis of Management; 2013-2020 (Million)
Table 19: US Intensively Managed Type1 Diabetic Population by Segment; 2015-2020
4.1.6 US CGM Market by Patient & Penetration
Table 20: US CGM Market by Patient & Penetration; 2013-2020 (Thousand)
4.2 Western Europe CGM Market: An Analysis
4.2.1 Western Europe CGM Market by Value
Table 21: Western Europe CGM Market by Value; 2015-2020 (US$ Million)
4.3 China CGM Market: An Analysis
4.3.1 China CGM Market by Value
Table 22: China CGM Market by Value; 2013-2024 (US$ Million)
4.3.2 China CGM Market by Segments
Table 23: China CGM Market by Segments; 2015-2024
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Population with Diabetes
Table 24: Global Population with Diabetes; 2009-2014 (Million)
5.1.2 Expanding Treatment Market for Type 1 Diabetes
Table 25: Global Treatment Market for Type 1 Diabetes; 2013-2023 (US$ Billion)
5.1.3 Rising Population with Obesity
Table 26: Global Population with Obesity; 2009-2014 (Million)
5.1.4 Factors Driving Recommendation for CGM
Table A: Factors Driving Recommendation for CGM
5.1.5 Sedentary Lifestyle
5.2 Challenges
5.2.1 Barriers to CGM Adoption by Type 1 Diabetes Patients
Table 27: Barriers to CGM Adoption by Type 1 Diabetes Patients
5.2.2 Discontinuation of CGM Use
5.2.3 Lack of Penetration in Type 2 Diabetes
5.2.4 Intense Competition
5.2.5 Regulatory Risk
5.3 Market Trends
5.3.1 Growing CGM Adoption
Table 28: CGM Adoption; 2016
5.3.2 Smartphone Sales to End Users
Table 29: Smartphone Sales to End Users; 2011-2015 (Million Units)
5.3.3 CGM Penetration
5.3.4 The Reimbursement and Pricing Landscape
5.3.5 Innovation in CGM
6. Competitive Landscape
6.1 Global Competitive Landscape
6.1.1 Global Players by CGM System Pricing
Table B: Global CGM Market Players by CGM System Pricing
6.1.2 Global Players by CGM Product Features
Table C: Global CGM Market Players by CGM Product Features
6.1.3 Global Players by CGM Market Share
Table 30: Global Players by Share; 2011-2015 (Percentage, %)
6.2 US Competitive Landscape
6.2.1 US Players by CGM Product Features
Table D: US CGM Market Players by CGM Product Features
6.2.2 US Players by CGM Market Share (Volume)
Table 31: US CGM Market Players by Share; 2015-2020
6.2.3 US Players by CGM Product Preference
Table 32: US CGM Players by Product Preference; 2015
7. Company Profile
7.1 Abott Laboratories
7.1.1 Business Overview
7.1.2 Financial Overview
Table 33: Abott Laboratories Net Sales; 2011-2015 (US$ Billion)
Table 34: Abott Laboratories Net Sales by Segments; 2015
7.1.3 Business Strategy
7.2 DexCom Incorporation
7.2.1 Business Overview
7.2.2 Financial Overview
Table 35: Dexcom Incorporation Revenue; 2011-2015 (US$ Million)
Table 36: Dexcom Incorporation Revenue by Segments; 2015
7.2.3 Business Strategy
7.3 Medtronic
7.3.1 Business Overview
7.3.2 Financial Overview
Table 37: Medtronic Net Sales; 2011-2015 (US$ Billion)
Table 38: Medtronic Net Sales by Segments; 2015
7.3.3 Business Strategy

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report